
Precautions for Dosage and Administration: At administration of this drug, be very cautious about especially change in neutrophil count, dose limiting factor of this drug, and if the neutrophil count of the day of administration is less than 2,000/mm3, the administration should be extended.
Pay attention that the bone-marrow suppression may be enhanced with increased dose of this drug. (See Precautions and Adverse Reactions.)
At administration of this drug, draw up the necessary amount into syringe, immediately mix with 250 mL or 500 mL of physiological saline or 5% glucose solution, and intravenously infuse over 1 hour or more. (See Cautions for Usage.)